We do the work so you don't get squeezed.

ShortSide Research is an independent research shop focused exclusively on the short side of US small caps. We analyze the daily gappers most retail desks ignore — sub-$500M floats, Chinese ADRs, biotech runners, SPAC re-rates, and serial diluters — and publish the structural risks that drive them.

Our edge is process, not opinion. Every name we cover is run through the same checklist: float and share structure, short interest and borrow availability, recent SEC filings (S-3s, ATM offerings, warrant exercises), reverse-split history, and catalyst quality. We score squeeze risk before the open, then publish a 4 PM recap so you can see how the morning's calls played out.

Everything we publish is for educational and informational purposes only. We are not your broker, your fiduciary, or your therapist. Size your own risk.